Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Edesa Biotech, Inc.
13D/A
Amendment 2
EDSA · 27966L306
|
10.0% |
8/25/2026
Event 8/21/2026
|
|||
| Velan Capital Master Fund LP | 8.0% | ||||
| Velan Horizon Fund LP | 0.2% | ||||
| Velan Capital Opportunity Fund II LLC | 1.9% | ||||
| Velan Horizon GP LLC | 0.2% | ||||
| Velan Capital Holdings LLC | 9.8% | ||||
| Velan Capital Investment Management LP | 10.0% | ||||
| Velan Capital Management LLC | 10.0% | ||||
| Morgan Adam | 10.0% | ||||
| Venkataraman Balaji | 10.0% | ||||
|
Jasper Therapeutics, Inc.
13G
JSPR · 471871202
|
9.9% |
8/17/2026
Event 8/17/2026
|
|||
| Velan Capital Master Fund LP | 8.9% | ||||
| Velan Capital Holdings LLC | 8.9% | ||||
| Velan Horizon Fund LP | 0.2% | ||||
| Velan Horizon GP LLC | 0.2% | ||||
| Avego Healthcare Capital, L.P. | 0.7% | ||||
| Avego Healthcare Capital Holdings, LLC | 0.7% | ||||
| Avego Management LLC | 0.7% | ||||
| Velan Capital Investment Management LP | 9.9% | ||||
| Velan Capital Management LLC | 9.9% | ||||
| Morgan Adam | 9.9% | ||||
| Venkataraman Balaji | 9.9% | ||||
| Kapoor Vishal | 0.1% | ||||
|
Jasper Therapeutics, Inc.
13D/A
Amendment 3
JSPR · 471871202
|
9.9% |
7/20/2026
Event 7/16/2026
|
|||
| Velan Capital Master Fund LP | 8.9% | ||||
| Velan Capital Holdings LLC | 8.9% | ||||
| Velan Horizon Fund LP | 0.2% | ||||
| Velan Horizon GP LLC | 0.2% | ||||
| Avego Healthcare Capital, L.P. | 0.7% | ||||
| Avego Healthcare Capital Holdings, LLC | 0.7% | ||||
| Avego Management LLC | 0.7% | ||||
| Velan Capital Investment Management LP | 9.9% | ||||
| Velan Capital Management LLC | 9.9% | ||||
| Morgan Adam | 9.9% | ||||
| Venkataraman Balaji | 9.9% | ||||
| Kapoor Vishal | 0.1% | ||||
|
InspireMD, Inc.
13G/A
Amendment 1
NSPR · 45779A846
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Velan Capital Master Fund LP | 4.99% | ||||
| Velan Capital Holdings LLC | 4.99% | ||||
| Velan Capital Investment Management LP | 4.99% | ||||
| Velan Capital Management LLC | 4.99% | ||||
| Morgan Adam | 4.99% | ||||
| Venkataraman Balaji | 4.99% | ||||
|
Edesa Biotech, Inc.
13D/A
Amendment 1
EDSA · 27966L306
|
10.0% |
3/2/2026
Event 2/26/2026
|
|||
| Velan Capital Master Fund LP | 6.8% | ||||
| Velan Horizon Fund LP | 0.2% | ||||
| Velan Capital Opportunity Fund II LLC | 3.0% | ||||
| Velan Horizon GP LLC | 0.2% | ||||
| Velan Capital Holdings LLC | 9.8% | ||||
| Velan Capital Investment Management LP | 10.0% | ||||
| Velan Capital Management LLC | 10.0% | ||||
| Morgan Adam | 10.0% | ||||
| Venkataraman Balaji | 10.0% | ||||
|
Jasper Therapeutics, Inc.
13D/A
Amendment 2
JSPR · 471871202
|
9.6% |
9/23/2025
Event 9/19/2025
|
|||
| Velan Capital Master Fund LP | 8.5% | ||||
| Velan Capital Holdings LLC | 8.5% | ||||
| Velan Horizon Fund LP | 0.1% | ||||
| Velan Horizon GP LLC | 0.1% | ||||
| Avego Healthcare Capital, L.P. | 0.9% | ||||
| Avego Healthcare Capital Holdings, LLC | 0.9% | ||||
| Avego Management LLC | 0.9% | ||||
| Velan Capital Investment Management LP | 9.6% | ||||
| Velan Capital Management LLC | 9.6% | ||||
| Morgan Adam | 9.6% | ||||
| Venkataraman Balaji | 9.6% | ||||
| Kapoor Vishal | 0.1% | ||||
|
InspireMD, Inc.
13G
NSPR · 45779A846
|
5.1% |
8/6/2025
Event 7/30/2025
|
|||
| Velan Capital Master Fund LP | 5.1% | ||||
| Velan Capital Holdings LLC | 5.1% | ||||
| Velan Capital Investment Management LP | 5.1% | ||||
| Velan Capital Management LLC | 5.1% | ||||
| Morgan Adam | 5.1% | ||||
| Venkataraman Balaji | 5.1% | ||||
|
Edesa Biotech, Inc.
13D
EDSA · 27966L306
|
10.0% |
2/18/2025
Event 2/12/2025
|
|||
| Velan Capital Master Fund LP | 6.2% | ||||
| Velan Horizon Fund LP | 0.2% | ||||
| Velan Capital Opportunity Fund II LLC | 3.6% | ||||
| Velan Horizon GP LLC | 0.2% | ||||
| Velan Capital Holdings LLC | 9.8% | ||||
| Velan Capital Investment Management LP | 10.0% | ||||
| Velan Capital Management LLC | 10.0% | ||||
| Morgan Adam | 10.0% | ||||
| Venkataraman Balaji | 10.0% | ||||